Apellis Pharmaceuticals
APLS
#4013
Rank
HK$17.06 B
Marketcap
HK$135.82
Share price
0.09%
Change (1 day)
-64.42%
Change (1 year)

EPS for Apellis Pharmaceuticals (APLS)

EPS in 2023 (TTM): -HK$41.12

According to Apellis Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$40.73. In 2022 the company made an earnings per share (EPS) of -HK$47.56 an increase over its 2021 EPS that were of -HK$68.67.

EPS history for Apellis Pharmaceuticals from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$41.12-13.54%
2022-HK$47.56-30.73%
2021-HK$68.6792.81%
2020-HK$35.61-11.73%
2019-HK$40.35123.18%
2018-HK$18.0827.08%
2017-HK$14.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$16.91-58.48%๐Ÿ‡บ๐Ÿ‡ธ USA